Related Experiment Video
Updated: Mar 8, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
Exendin-4 Upregulates Adiponectin Level in Adipocytes via Sirt1/Foxo-1 Signaling Pathway
Anping Wang1, Ting Li1, Ping An1
1Department of Endocrinology, Chinese PLA General Hospital, Beijing, China.
Abstract:
Glucagon-like peptide-1 (GLP-1) receptor plays an essential role in regulating glucose metabolism. GLP-1 receptor agonists have been widely used for treating diabetes and other insulin resistance-related diseases. However, mechanisms underlying the anti-diabetic effects of GLP-1 receptor agonists remain largely unknown. In this study, we investigated the effects of GLP-1 agonist exendin-4 on the expression of adiponectin, an insulin sensitizing hormone. We found that exendin-4 increased the expression and secretion of adiponectin both in vitro and in vivo. Our data showed that exendin-4 upregulated adiponectin expression at both mRNA and protein levels in adipocytes and adipose tissues. The effects of exendin-4 on adiponectin expression were dependent on the GLP-1 receptor. We further demonstrated important roles of Sirt1 and transcriptional factor Foxo-1 in mediating the function of exendin-4 in regulating adiponectin expression. Suppression of Sirt1 or Foxo-1 expression significantly impaired exendin-4-induced adiponectin expression. Consistently, exendin-4 up-regulated Sirt1 and Foxo-1 expression in vivo. Our work is the first study demonstrating the role of Sirt1/Foxo-1 in regulating the regulatory function of a GLP-1 receptor agonist in adiponectin expression both in vitro and in vivo. The results provide important information for the mechanism underlying the function of GLP-1R on improving insulin resistance and related diseases.
Insights
Glucagon-like peptide-1 (GLP-1) receptor agonist exendin-4 boosts adiponectin, an insulin-sensitizing hormone. This study reveals exendin-4
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolic Diseases
Background:
- Glucagon-like peptide-1 (GLP-1) receptor agonists are utilized for diabetes and insulin resistance.
- The precise mechanisms behind their anti-diabetic effects are not fully understood.
Purpose of the Study:
- To investigate the impact of the GLP-1 receptor agonist exendin-4 on adiponectin expression.
- To elucidate the molecular pathways, including Sirt1 and Foxo-1, involved in this regulation.
Main Methods:
- In vitro and in vivo experiments using adipocytes and adipose tissues.
- Analysis of adiponectin, Sirt1, and Foxo-1 expression at mRNA and protein levels.
- GLP-1 receptor dependency studies and gene suppression experiments.
Main Results:
- Exendin-4 significantly increased adiponectin expression and secretion.
- These effects were mediated through the GLP-1 receptor.
- Sirt1 and Foxo-1 were identified as key mediators, with exendin-4 upregulating their expression.
Conclusions:
- Exendin-4 enhances adiponectin expression via the GLP-1 receptor, involving Sirt1 and Foxo-1.
- This provides novel insights into the mechanisms by which GLP-1 receptor agonists improve insulin resistance.
More Related Videos
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Insulin: The Receptor and Signaling Pathways
Cell Specific Gene Expression
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway
Regulation of Food Intake

